It is with profound sadness that we learn of the passing of Rob Burrow, a true friend and fierce advocate in the fight against motor neuron disease. Rob was a remarkable athlete but, more importantly, an extraordinary human being.

Doddie and Rob shared a unique bond, both as legendary rugby players and as warriors against this devastating disease. Rob’s efforts, alongside Kevin Sinfield, have galvanised the MND community and beyond, raising significant funds and awareness.

Rob’s spirit and unwavering positivity in the face of adversity have left an indelible mark. His journey, shared so openly, has brought much-needed attention to MND, and his legacy will inspire future generations.

Our thoughts and deepest condolences go out to Rob’s wife Lindsey, their children Macy, Maya, and Jackson, and all of Rob’s family and friends. The rugby community and the MND community have lost a giant, but the impact of Rob’s work and spirit will endure. We remain committed to a world free of MND, driven by the memory and example of incredible people like Rob, and we will continue to push forward in our quest for a cure.

More news & stories

View all
 picture
Research
23 Sep 2026

Topline announcement of Phase 3 trial results for FUS-MND appear promising

Yesterday, the companies Otsuka and Ionis announced the results of their Phase 3 trial of the genetic therapy, ulefnersen. Ulefnersen targets a rare form of MND…
Read more
 picture
MND stories Research
14 Sep 2026

R.A.C.E. to Diagnose: New training programme to speed up MND diagnosis

For Andy Vaughton, receiving a motor neuron disease (MND) diagnosis in 2021 finally provided an answer for symptoms he had been struggling with for several years.…
Read more
 picture
Fundraising MND stories
10 Sep 2026

"I love you, and this is for you": Cammy cycles over 1,000 miles in memory of his Dad

This year, Cammy Jones has taken on two long-distance cycling challenges for My Name’5 Doddie Foundation: Doddie’s Triple Crown, which saw him ride from Melrose…
Read more
Bell icon

Join our Newsletter!

By subscribing, you confirm that you agree with our terms and conditions.